KaNDy Therapeutics announces the appointment of Andrew Kay as Independent Chairman of the Board

Dr Mary Kerr CEO KaNDy Therapeutics presents at the Biotech Showcase, San Francisco

7th January 2019: KaNDy Therapeutics CEO, Dr Mary Kerr, presents at the Biotech Showcase, 15:30 Franciscan – C (Ballroom Level), Hilton San Francisco, San Francisco, CA 94102, USA

KaNDy Therapeutics announces initiation of Phase 2b trial of NT-814 for the treatment of troublesome post-menopausal symptoms

Contact Us

Please fill out the form to get in touch with us.

Not readable? Change text. captcha txt